Clinical Trial Update: Modulation of Inflammation by Medium Cut Off Membranes [NA]

View source ↗

Summary

This document reports an ongoing clinical trial sponsored by Technical University of Munich investigating inflammation modulation using medium cut off membranes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• End-stage Renal Disease

Snippet

Sponsor: Technical University of Munich | Conditions: Cardiovascular Diseases, End Stage Renal Disease | NA | Status: UNKNOWN